1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Organigram Global Inc.

Organigram Global Inc.

OGI
Organigram Global Inc.US flagNASDAQ Global Select
1.06
USD
-0.03
- -
149.22MMarket Cap

Total Valuation

Organigram Global Inc. carries a market capitalization of 149.22M, placing it among publicly traded companies globally. Its enterprise value stands at 251.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap149.22M
Enterprise Value251.87M

Share Statistics

Organigram Global Inc. currently has 136.47M shares outstanding.

Shares Outstanding136.47M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Organigram Global Inc. trades at a trailing price-to-earnings ratio of 34.90. The price-to-sales ratio is 0.91, and the price-to-book ratio stands at 0.74.

PE Ratio34.90
PS Ratio0.91
PB Ratio0.74
P/TBV Ratio0.89
P/FCF Ratio154.85
P/OCF Ratio-25.92

Enterprise Valuation

On an enterprise value basis, Organigram Global Inc. trades at an EV/EBITDA multiple of 44.70 and an EV/FCF ratio of 156.05.

EV / Sales0.92
EV / EBITDA44.70
EV / EBITN/A
EV / FCF156.05

Financial Position

Organigram Global Inc. maintains a current ratio of 2.82, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

Current Ratio2.82
Quick Ratio0.66
Debt / Equity2.20
Debt / EBITDA1.45
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)-7.34
Return on Assets (ROA)-4.76
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)5.70
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.41

Taxes

Income Tax-13.66M
Effective Tax RateN/A

Stock Price Statistics

Organigram Global Inc.'s stock has declined approximately -20.30075% over the past 52 weeks. The 50-day moving average sits at 1.31, while the 200-day moving average is 1.55.

Beta (5Y)N/A
52-Week Price Change-20.30075%
50-Day Moving Average1.31
200-Day Moving Average1.55
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Organigram Global Inc. generated 274.19M in revenue and converted that into -25.21M in net income, yielding earnings per share of -0.19. EBITDA reached 5.64M, while operating income came in at -14.13M.

Revenue274.19M
Gross Profit97.71M
Operating Income-14.13M
Pretax Income-38.87M
Net Income-25.21M
EBITDA5.64M
EBIT-14.13M
Earnings Per Share (EPS)-0.19

Balance Sheet

Organigram Global Inc. holds 5.10M in cash and equivalents against 8.20M in total debt, resulting in a net debt position of -4.29M. Total book value stands at 334.51M, with working capital of 161.34M providing operational flexibility.

Cash & Cash Equivalents5.10M
Total Debt8.20M
Net Debt-4.29M
Equity (Book Value)334.51M
Book Value Per Share2.51
Working Capital161.34M

Cash Flow

Organigram Global Inc. produced -9.60M in operating cash flow over the past twelve months. After subtracting -11.21M in capital expenditures, free cash flow totaled -20.81M - equivalent to -0.16 per share.

Operating Cash Flow-9.60M
Capital Expenditures-11.21M
Free Cash Flow-20.81M
FCF Per Share-0.16

Margins

Organigram Global Inc. operates with a gross margin of 35.64, reflecting its pricing power and cost economics. The operating margin of -5.15 and net profit margin of -9.19 provide insight into operational efficiency.

Gross Margin35.64
Operating Margin-5.15
Pretax Margin-14.18
Profit Margin-9.19
EBITDA Margin2.06

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield0.81
FCF Yield0.65

Stock Splits

Organigram Global Inc.'s most recent stock split took place on July 7, 2023 with a 4:1 split ratio.

Last Split Date7/7/2023
Split Ratio4:1

Scores

Organigram Global Inc. posts an Altman Z-Score of 0.06, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.06